1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 22 JUNE 2015

Cancer Drug News 22 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Gardasil 9 To Keep Merck On Top Of HPV Market
Industry Brief - Vaxil's ImMucin Gains FDA ODD For MM
Industry Trend Analysis - Myelofibrosis Market Changes Imminent
Industry Brief - Vosaroxin/Cytarabine Phase III Study Yields Positive Results In Older r/r AML Patients
Industry Brief - Phase II Tosedostat Combination Study Meets Primary Endpoint In Elderly AML Patients
Industry Brief - Vectibix Significantly Improves OS Versus Supportive Care In Phase III MCRC Study
Industry Trend Analysis - Anti-PD-1 Battle To Intensify In Europe
Industry Brief - OncoSec Enrols First Patient In Phase II ImmunoPulse IL-12 Trial In SCCHN
Industry Brief - VG Life Sciences Granted Combination Cancer Drug Patent
Industry Brief - Vaxon Granted Japanese Patent Covering Cancer Vaccine Candidates
Industry Brief - Western Oncolytics Raises Funds To Advance Cancer Oncolytic Immunotherapy
Industry Brief - Celyad Raises USD100.1mn With NASDAQ IPO
Industry Brief - CytomX Raises Funds To Advance Probody Therapeutics For Cancer
Industry Brief - Daiichi Sankyo Begins Phase III Edoxaban Study For Cancer-Associated VTE
Industry Brief - Cancer Conferences - September 2015

Table Of Contents

Cancer Drug News 22 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.